Shanmuga Hospital claims to have a dedicated oncology department with specialised oncologists and advanced treatment facilities.
The hospital claims to offer high-quality healthcare services at affordable rates. It has structured financial assistance programs and cost-efficient measures to reduce medical expenses.
Shanmuga Hospital claims to have advanced medical equipment, including a Linear Accelerator (LINAC) for radiation therapy, a Catheterisation Laboratory (CATHLAB) for cardiology, MRI scanners, and Modular Operation Theatres for complex surgeries.
The hospital is accredited by the National Accreditation Board for Hospitals and Healthcare (NABH) and the National Accreditation Board for Testing and Calibration Laboratories (NABL).
Shanmuga Hospital is empanelled with various government agencies and private insurance companies. The hospital has agreements with ESIC, Railway Hospital, ECHS, Airport Authority of India, and Food Corporation of India.
Shanmuga Hospital operates a 151-bed facility in Salem and provides a range of specialised medical services.
The top 10 suppliers of Shanmuga Hospital contributed 30.91%, 30.46%, 25.82%, and 28.41% of total medicine purchases during the period ending September 2024, FY24, FY23, and FY22, respectively. The company does not have long-term agreements with these suppliers. Any failure to retain key suppliers, secure timely deliveries, or manage supply chain disruptions could adversely affect the company’s operations, financial condition, and profitability.
Shanmuga Hospital operates only one multispecialty hospital in Salem, Tamil Nadu. Any adverse political, social, or economic developments in this region, including natural disasters or infrastructure disruptions, could negatively impact the company’s business, financial position, and ability to serve patients.
As of September 30, 2024, the company had long-term borrowings of Rs 3.59 crore. Any failure to service or repay these loans can harm the company’s operations and financial position.
The top 10 government and corporate clients of Shanmuga Hospital contributed 43.01%, 45.70%, 48.51%, and 44.98% of total revenues for the period ending September 2024, FY24, FY23, and FY22, respectively. Any failure to retain these key customers, expand the customer base or a loss of business from these clients could adversely affect the company’s business and financial standing.
The company, group companies, promoters and directors are involved in certain ongoing legal proceedings. Any adverse judgments in any of these cases could be detrimental to the company’s business prospects.
A portion of the hospital’s revenue comes from government-sponsored health schemes. Any sudden changes in regulations or policies related to these schemes could negatively impact the hospital’s business operations and financial performance.
The hospital's revenue is largely dependent on inpatient services. A decline in the number of inpatient treatments could impact its financial stability and overall performance.